Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
作者信息
Jones R N, Barry A L
机构信息
Clinical Microbiology Institute, Tualatin, Oregon.
出版信息
Eur J Clin Microbiol. 1987 Oct;6(5):570-1. doi: 10.1007/BF02014248.
PMID:3501757
Abstract
A novel 1-carbacephem, LY163892, was determined to be more stable to plasmid-mediated beta-lactamases than cefaclor. Chromosomal-mediated Type Ia and IVc enzymes destroyed LY163892 at rates ranging from 16 to 93% that of nitrocefin. LY163892 showed minimal ability to inhibit beta-lactamases other than Type Ia (P99).
摘要
Zotero 插件